GALVANY DEVELOPMENTS LTDActive
Key figures
Like most small UK companies, GALVANY DEVELOPMENTS LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2025Balance sheet structure
Filed accounts2020/21–2025
| 2020/21 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Cash at bank and in hand | — | 833,950 | 303,498 | 49,973 | 3,958 |
| Total assets | 100 | 2,805,613 | 2,358,072 | 1,637,279 | 221,173 |
| Total liabilities | — | — | — | — | — |
| Net assets / total equity | -200 | 1,265,089 | 945,277 | 212,142 | 172,279 |
| Average number of employees | 0 | 0 | 0 | 3 | 3 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: GALVANY DEVELOPMENTS LTD
Company
GALVANY DEVELOPMENTS LTD is a private limited company registered with Companies House under company number 10971673. It was incorporated on 19 Sep 2017. Its status is active. The registered office is in Stevenage (SG1). Its nature of business (SIC 2007) is manufacture of basic pharmaceutical products (21100), manufacture of pharmaceutical preparations (21200), wholesale of pharmaceutical goods (46460), research and experimental development on biotechnology (72110).
Accounts
The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files small company accounts (filleted). Net assets were £172,279, down 18.8% on the previous year. Cash at bank and in hand was £3,958. The company had an average of 3 employees. Figures are available for 5 financial years (2020/21–2025).
Control and charges
One person with significant control is registered.
Filing deadlines
The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 15 Sep 2027.